RecruitingNCT03999983
Vertebral Artery Origin Treatment Via Endovascular Techniques Registry (VOTER)
Sponsor
St. Louis University
Enrollment
150 participants
Start Date
Nov 19, 2019
Study Type
OBSERVATIONAL
Conditions
Summary
A retrospective and prospective registry of patients admitted for stroke and evidence of Vertebral Artery Origin Stenosis (VAOS).
Eligibility
Min Age: 18 YearsMax Age: 90 Years
Inclusion Criteria4
- Patients between 18 and 90 years of age
- Patient has experienced a posterior circulation ischemic event
- Patient has angiographically confirmed bilateral vertebral artery origin disease (Hypoplasia, occlusion, or stenosis).
- Patient has >50% stenosis on the side being targeted for therapy
Exclusion Criteria6
- Pregnant women
- Contrast Indication to the use of anti-platelet drugs
- There is tandem vertebral or basilar artery stenosis
- The serum creatinin is >2.5
- Baseline modified Rankin score is >3
- < 5 years life expectancy
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERObservational Prospective Registry
This is a prospective registry looking at patients admitted for stroke with evidence of Vertebral Artery Origin Stenosis. Patients clinical outcomes will be collected at 30 days and 1-year post-treatment and angiographic outcomes at 1-year post-treatment
Locations(10)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03999983
Related Trials
A Prospective, Experimental, Multicenter, Open-label, Randomized, Controlled Trial of 3-month Dual Antiplatelet Therapy Followed by Ticagrelor Versus 6-month Dual Antiplatelet Therapy Followed by Ticagrelor After Implanting Bridge
NCT063017761 location
Drug-eluting Stenting Versus Medical Treatment for Extracranial Vertebral Artery Stenosis
NCT058859321 location
Efficacy of Drug-Eluting Vertebral Artery Stenting Treatment for Atherosclerotic Vertebral Arteries Stenosis
NCT056443141 location